Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, B-Cell, Marginal Zone

Explore clinical trials studying Lymphoma, B-Cell, Marginal Zone. Study availability and eligibility vary by location and protocol.

645 public trials 88 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, B-Cell, Marginal Zone trial results

Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

NCT05780034

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
View Trial Details
Recruiting

Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma

NCT06082102

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Auhui, China
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 19 locations
View Trial Details

Related conditions